CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale Director sold 5,441 shares at $35.13 ($191,142)
- 4 Planned sale Director sold 29,941 shares at an average $35.32 ($1,057,460)
- 4 Planned sale Director sold 30,974 shares at an average $35.50 ($1,099,697)
- 4 Planned sale Director sold 3,617 shares at an average $35.14 ($127,102)
- 4 Planned sale Director sold 120,242 shares at an average $36.07 ($4,336,893)
- 4 Planned sale Director sold 80,293 shares at an average $36.15 ($2,902,720)
- 4 Planned sale Chief Operating Officer sold 8,976 shares at $34.41 ($308,864)
- 4 Planned sale SVP, Head of Finance & Admin. sold 1,390 shares at $34.55 ($48,025)
- 4 Planned sale Chief Scientific Officer sold 2,339 shares at $34.55 ($80,812)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 4,592 shares at an average $35.10 ($161,198)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Scientific Officer sold 2,161 shares at $31.89 ($68,914)
Page 17 of 40 · 796 filings